top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Harvey J. Berger, M.D., assumes leadership roles as Chairman, President, and CEO at Kojin Therapeutics

Boston, MA, January 03, 2024 (Business Wire) -- Kojin Therapeutics, Inc., focused on cell-state and ferroptosis biology, and innovative drug discovery, has appointed Harvey J. Berger, M.D., as its new Chairman, President, and CEO. A seasoned physician-scientist and entrepreneur with over 35 years of global R&D, corporate, and commercial leadership. Dr. Berger will leverage his significant experience from founding ARIAD Pharmaceuticals where he led the company to become a fully integrated global oncology pioneer. Under his guidance, six groundbreaking medicines for cancer, cardiovascular disease, autoimmune disease, and a cancer-diagnostic blood tests received development and approval.


Read full article here.

Recent Posts

See All

Comments


Life Science Headlines

© 2024 by Jacobs Management Group, Inc.

​

Privacy Policy

​

bottom of page